We are live on ! Find out more
NFH.WS

New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
NFH.WS

Delisted

NFH.WS was delisted on the 26th of January, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 9 → 0 (-9)

100% less capital invested

Capital invested by funds: $11.5M → $0 (-$11.5M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 9

Holders
–
Holders Change
-9
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
NFGH
Nan Fung Group Holdings
Hong Kong
-$4.27M
2
AA
AQR Arbitrage
Connecticut
-$3.3M
3
SCM
Segantii Capital Management
Hong Kong
-$2.23M
4
MAM
Myriad Asset Management
Hong Kong
-$491K
5
LA
Linden Advisors
New York
-$478K

NFH.WS Hedge Fund Activity: Q1 2022 in Review

0 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) for Q1 2022, worth a combined $0 — down 100% from $11.5M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of NFH.WS and 0 opened new positions — a net loss of 9 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Nan Fung Group Holdings, exiting entirely with an estimated $4.27M sold.

  • 0 institutional investors held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) as of Q1 2022, down from 9 in Q4 2021.
  • Funds reported $0 of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a stock for Q1 2022, down 100% quarter-over-quarter.
  • 0 funds opened new New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a positions in Q1 2022 and 9 closed out, a net change of -9 holders.
  • The largest New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a seller in Q1 2022 was Nan Fung Group Holdings, an estimated $4.27M sold.

Based on aggregated 13F filings for Q1 2022.